Wachowska, Malgorzata http://orcid.org/0000-0001-7199-9649
Stachura, Joanna
Tonecka, Katarzyna
Fidyt, Klaudyna
Braniewska, Agata
Sas, Zuzanna
Kotula, Iwona
Rygiel, Tomasz Piotr http://orcid.org/0000-0003-4746-6505
Boon, Louis
Golab, Jakub http://orcid.org/0000-0002-2830-5100
Muchowicz, Angelika http://orcid.org/0000-0003-4707-1722
Funding for this research was provided by:
Narodowe Centrum Nauki (UMO-2014/13/D/NZ6/01080)
Horizon 2020 (STREAM 692180)
Ministerstwo Nauki i Szkolnictwa Wyższego (iONCO)
Article History
Received: 13 June 2019
Accepted: 17 February 2020
First Online: 28 February 2020
Compliance with ethical standards
:
: Mammary carcinoma 4T1 cell line was obtained from American Type Culture Collection (CRL-2539). The E0771 breast cancer cell line (C57BL/6-derived) was purchased from CH3 Biosystems LLC. Both cell lines have been cultured no longer than 3 weeks after thawing and used for the experiments without any further authentication. All cell lines were routinely tested for mycoplasma contamination with PCR technique.
: The authors declare no conflict of interest.
: All in vivo experiments were carried out according to the European Union Directive 2010/63/EU for animal experiments and were approved by the ethics committee named: The II Local Ethics Committee at the Medical University of Warsaw in Warsaw, Poland, in the statements from July 12, 2012, to October 11, 2019.
: Mice were obtained from the Animal House of the Polish Academy of Sciences, Medical Research Center (Warsaw, Poland).